US Broker Ratings

Genmab A/S (GMAB) Stock Analysis: Exploring a 41.59% Potential Upside in the Biotech Sector

Genmab A/S (NASDAQ: GMAB), a prominent biotechnology company headquartered in Copenhagen, Denmark, is generating significant interest among investors, particularly due to its robust potential upside of 41.59%. As a key..

ICON plc (ICLR)

⚠️ No article content returned.

..

Globus Medical, Inc. (GMED) Stock Report: A 20.52% Upside Potential in the Medical Devices Sector

Globus Medical, Inc. (NYSE: GMED), a key player in the healthcare sector specializing in medical devices, is catching the attention of investors with its impressive growth trajectory and promising market..

Regeneron Pharmaceuticals, Inc. (REGN)

⚠️ No article content returned.

..

CVS Health Corporation (CVS) Stock Analysis: A Promising 17.65% Upside Amid Robust Sector Positioning

Investor interest in CVS Health Corporation (NYSE: CVS) is on the rise as the healthcare giant navigates the evolving landscape of healthcare services with strategic precision. With a market capitalization..

Abbott Laboratories (ABT) Stock Analysis: Navigating a Potential 32.62% Upside with Solid Dividends

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector with a focus on medical devices, presents a compelling opportunity for investors seeking stability paired with growth potential. With a..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 45% Potential Upside Awaits Investors

IQVIA Holdings, Inc. (NYSE: IQV), a prominent player in the healthcare sector specializing in diagnostics and research, is capturing the attention of investors with its robust growth potential and compelling..

West Pharmaceutical Services (WST): An In-Depth Stock Analysis Reveals 16.35% Potential Upside

As healthcare continues to be a focal point of global investment, West Pharmaceutical Services, Inc. (NYSE: WST) stands out as a robust player in the Medical Instruments & Supplies industry...

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 31.61% Potential Upside in the Healthcare Tech Market

Tempus AI, Inc. (TEM) is carving out a distinctive niche within the healthcare technology sector by harnessing advanced AI capabilities to drive innovation in health information services. Based in Chicago..

Hologic, Inc. (HOLX) Stock Analysis: Exploring the Healthcare Giant’s Strong Position with Limited Upside

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, particularly in medical instruments and supplies, boasts a robust market capitalization of $16.97 billion. With its headquarters in Marlborough,..

Roivant Sciences Ltd. (ROIV) Stock Analysis: A 28% Upside in Biotech Innovation

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 28.16%, according to the latest analyst ratings. As a..

Incyte Corporation (INCY) Stock Analysis: Unveiling a 12% Potential Upside in the Biotech Sector

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, presents an intriguing investment opportunity with its robust pipeline and a notable potential upside of nearly 12%. As the..

Chemed Corp (CHE) Stock Analysis: Navigating Healthcare Growth with a 5.77% Upside Potential

Chemed Corp (NYSE: CHE), a stalwart in the healthcare sector, has carved a notable niche within the medical care facilities industry. With a market capitalization of $5.6 billion, the company..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Examining the Strategic Healthcare Player with a 26.5% Revenue Growth

Medpace Holdings, Inc. (NASDAQ: MEDP) stands out as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $11.92 billion, this..

Royalty Pharma plc (RPRX): Analyst Consensus Signals Potential Upside Amid Biotech Growth

Royalty Pharma plc (NASDAQ: RPRX) stands as a prominent player in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $29.33 billion, this New York-based company..

Medtronic plc (MDT) Stock Analysis: Uncovering a 35% Upside Potential

Medtronic plc (MDT), a giant in the medical devices industry, commands a market capitalization of $102.71 billion and stands as a vital player in the healthcare sector. Headquartered in Galway,..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 37% Potential Upside

AptarGroup, Inc. (NYSE: ATR) has long been a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $7.66 billion, the..

Viatris Inc. (VTRS) Stock Analysis: Is This Healthcare Giant Poised for a 4.54% Upside?

Viatris Inc. (VTRS), a formidable player in the healthcare sector, has captured investor attention with its diverse portfolio and strategic global presence. With a market capitalization of $17.51 billion, Viatris..

DexCom, Inc. (DXCM) Stock Analysis: Unveiling a 36% Upside Potential Amidst Robust Revenue Growth

For investors focusing on the healthcare sector, DexCom, Inc. (NASDAQ: DXCM) presents an intriguing opportunity with its significant upside potential and robust revenue growth. Specializing in continuous glucose monitoring (CGM)..

Penumbra, Inc. (PEN) Stock Analysis: A 12.44% Potential Upside in the Thriving Medical Devices Sector

Penumbra, Inc. (NYSE: PEN), a prominent player in the healthcare sector, specifically in the medical devices industry, showcases significant growth potential for investors eyeing the burgeoning market for innovative medical..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds